This is a specific type of paraneoplastic syndrome that affects the nerves. It happens in people with cancer. The cancer causes the nerves to malfunction, often due to substances the cancer produces. This can lead to various neurological problems, like muscle weakness, numbness, or problems with balance and coordination. It's important to remember this is not the cancer cells directly invading the nerves.
Every report comes from a Lived member, sent anonymously.
Have you tried IVIG for Nervous System Paraneoplastic Syndromes?
Nervous system paraneoplastic syndromes are rare disorders in which the body's immune response to a cancer also attacks part of the brain, spinal cord, nerves or muscles. The damage is not caused by the tumor spreading into the nervous system. Instead, some tumors make proteins that are also found in nerve cells. When the immune system targets the tumor, it can mistake those nerve cells for the cancer. These syndromes can affect almost any part of the nervous system, so they look different from person to person. Some cause memory loss, confusion, mood or behavior changes and seizures (a form called limbic encephalitis). Others cause rapidly worsening unsteadiness, slurred speech and trouble coordinating movement, numbness and loss of position sense in the limbs, or weakness of the hips and shoulders with a dry mouth and constipation (Lambert-Eaton myasthenic syndrome). A typical feature is that symptoms develop over days to weeks, often reaching a severe level within about three months, which is faster than most degenerative nerve diseases. The neurologic problem often appears before anyone knows there is a cancer. For that reason, these syndromes matter both as neurologic illnesses and as a clue that leads to finding a tumor, sometimes while it is still small.
The underlying cause is a cancer that provokes an immune reaction against the nervous system. Small cell lung cancer is the tumor most often involved. Breast, ovarian and other gynecologic cancers, testicular tumors, thymoma (a tumor of the thymus gland in the chest) and Hodgkin lymphoma are also associated. In children, a related syndrome of jerking eye and body movements is linked to neuroblastoma, a childhood nerve-tissue cancer. Why only a small share of people with these cancers develop a paraneoplastic syndrome is not known. Age, sex and a history of smoking change which tumors are likely, because they change which cancers are likely in the first place. Some of the same neurologic syndromes also occur without any cancer, as an autoimmune condition on its own. Cancer treatment with immune checkpoint inhibitors, medicines that release the brakes on the immune system so it attacks tumors, can occasionally trigger or worsen a similar neurologic syndrome in someone whose cancer is already known.
Diagnosis starts with recognizing a pattern: a neurologic problem that develops quickly, has no other explanation, and fits one of the syndromes known to accompany cancer. A neurologist examines the person and usually orders an MRI of the brain or spine, nerve and muscle tests, and a lumbar puncture (spinal tap) to look for inflammation in the fluid around the brain and spinal cord. Other causes are ruled out, including infection, the effects of chemotherapy or other medicines, vitamin deficiencies and cancer that has spread to the nervous system. Blood and spinal fluid are tested for antibodies against nerve proteins. Testing both samples is recommended because some antibodies show up in only one. Certain antibodies point strongly to a hidden cancer and even to its likely type. Antibody results can be falsely positive or negative, and some people with a paraneoplastic syndrome have no detectable antibody, so a negative test does not rule it out. When a paraneoplastic syndrome is suspected, a search for cancer follows, usually a CT scan of the chest, abdomen and pelvis, and a PET scan if the CT finds nothing. A PET scan highlights tissue that is using a lot of energy, which can reveal a small tumor the CT missed. Depending on the person, this can include a mammogram, a testicular or pelvic ultrasound, or a skin check. If no tumor is found but the syndrome and antibody strongly suggest one, scans are typically repeated every four to six months for about two years, because the cancer may be too small to see at first.
Treatment has two parts that run together: treating the cancer and calming the immune attack on the nervous system. Specialists aim to start both as soon as possible, because nerve cells destroyed by the immune response often do not recover. When the clinical picture is convincing, immune treatment is often started before antibody results come back. Removing or treating the tumor with surgery, chemotherapy or radiation removes the source of the immune trigger and, in some syndromes, is the treatment that helps the nervous system most. First-line immune treatments include high-dose corticosteroids given into a vein, intravenous immunoglobulin (IVIG, antibodies pooled from donated blood that dampen the harmful immune response) and plasma exchange (a procedure that filters antibodies out of the blood). These may be combined. If they are not enough, or for longer-term control, specialists may use stronger immune-suppressing medicines such as rituximab (an antibody infusion that removes the immune cells that make antibodies) or cyclophosphamide (a chemotherapy medicine that is also used to suppress the immune system). Because these treatments lower the body's defenses, the trade-off is a higher risk of infection, which matters more for someone also receiving chemotherapy, and they require regular monitoring. Symptom care is part of treatment too: seizure medicines, treatment for nerve pain, and physical, occupational and speech therapy. In Lambert-Eaton myasthenic syndrome, amifampridine (Firdapse), a tablet that helps nerves pass signals to muscles, can ease weakness. There are few clinical trials in these rare conditions, so most treatment plans are based on specialist experience, and care is best coordinated between neurology and oncology.
The course varies widely. It depends on which part of the nervous system is affected, which antibody is involved, how quickly treatment starts and how the cancer responds. Syndromes caused by antibodies against the surface of nerve cells, and some that affect the nerves and muscles rather than the brain, more often improve with treatment. Syndromes linked to antibodies against proteins inside nerve cells, such as many forms that affect the cerebellum (the part of the brain that coordinates movement), tend to cause lasting damage, and treatment more often aims to stop worsening than to reverse it. Improvement, when it comes, is uneven. Seizures and nerve pain may ease within four to six weeks of starting immune treatment, while memory, strength, balance and sensation recover much more slowly, if at all. Many people live with some lasting disability and need help with walking, daily tasks or communication. Rehabilitation, mobility aids and support at home can make a real difference to independence. Follow-up usually involves both a neurologist and a cancer specialist. It includes repeated examinations, sometimes repeat MRI or nerve tests to judge whether the immune treatment is working, and, if no cancer was found at first, scheduled scans to look for one. Overall outlook often depends as much on the cancer as on the neurologic syndrome.
See a doctor promptly, within days rather than weeks, for neurologic symptoms that are getting worse over days to weeks, such as memory problems, confusion or personality change, unsteady walking, slurred speech or double vision, spreading numbness, or new weakness, especially if you have had cancer or are a current or former smoker. Early assessment matters because treatment works best before nerve damage becomes permanent. If you are receiving an immune checkpoint inhibitor or are being treated for a paraneoplastic syndrome, contact your care team the same day about any new or worsening neurologic symptom or signs of infection such as fever. This includes seizures that become more frequent or change in pattern, and swallowing that becomes newly difficult. Call 911 for a first-ever seizure, a seizure lasting more than 5 minutes, seizures one after another without waking up in between, trouble breathing, choking, or being unable to swallow saliva.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Nervous System Paraneoplastic Syndromes is like, what's helped you, or ask the community a question.